-
1
-
-
84856882574
-
Effect of quetiapine and norquetiapine on anxiety and depression in major psychosis using a pharmacokinetic approach a prospective observational study
-
doi:10.2165/11597330-000000000-00000
-
Altamura, A.C., Moliterno, D., Paletta, S., Buoli, M., Dell'Osso, B., Mauri, M.C., & Bareggi, S.R. (2012). Effect of quetiapine and norquetiapine on anxiety and depression in major psychosis using a pharmacokinetic approach a prospective observational study. Clinical Drug Investigation, 32, 213-219.doi:10.2165/11597330-000000000-00000
-
(2012)
Clinical Drug Investigation
, vol.32
, pp. 213-219
-
-
Altamura, A.C.1
Moliterno, D.2
Paletta, S.3
Buoli, M.4
Dell'Osso, B.5
Mauri, M.C.6
Bareggi, S.R.7
-
2
-
-
84870469320
-
-
American Psychiatric Association, (4th ed., text rev.). Washington, DC:Author
-
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC:Author.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
3
-
-
33745737632
-
Neuroleptic drugs in dementia: Benefits and harm
-
Ballard, C., & Howard, R. (2006). Neuroleptic drugs in dementia: Benefits and harm. Nature Reviews Neuroscience, 7, 492-500.
-
(2006)
Nature Reviews Neuroscience
, vol.7
, pp. 492-500
-
-
Ballard, C.1
Howard, R.2
-
4
-
-
20244384575
-
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial
-
Ballard, C., Margallo-Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A., Jacoby, R. (2005). Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial. BMJ, 330, 874-877.
-
(2005)
BMJ
, vol.330
, pp. 874-877
-
-
Ballard, C.1
Margallo-Lana, M.2
Juszczak, E.3
Douglas, S.4
Swann, A.5
Thomas, A.6
Jacoby, R.7
-
5
-
-
77953500268
-
Extended release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placeboand active-controlled study
-
doi:10.1017/S1461145709990423
-
Bandelow, B., Chouinard, G., Bobes, J., Ahokas, A., Eggens, I., Liu, S., & Eriksson, H. (2010). Extended release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placeboand active-controlled study. International Journal of Neuropsychopharmacology, 13, 305-320. doi:10.1017/S1461145709990423
-
(2010)
International Journal of Neuropsychopharmacology
, vol.13
, pp. 305-320
-
-
Bandelow, B.1
Chouinard, G.2
Bobes, J.3
Ahokas, A.4
Eggens, I.5
Liu, S.6
Eriksson, H.7
-
7
-
-
77951227428
-
A pilot study of quetiapine in patients with bipolar disorder and cocaine dependence
-
Brown, E.S., Gabrielson, B., & Gu, P. (2010). A pilot study of quetiapine in patients with bipolar disorder and cocaine dependence. Journal of Dual Diagnosis, 6, 16-24.
-
(2010)
Journal of Dual Diagnosis
, vol.6
, pp. 16-24
-
-
Brown, E.S.1
Gabrielson, B.2
Gu, P.3
-
8
-
-
68649100415
-
Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients
-
doi:10.1007/s10597-009-9200-0
-
Cates, M.E., Jackson, C.W., Feldman, J.M., Stimmel, A.E., & Woolley, T.W. (2009). Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Mental Health Journal, 45, 251-254. doi:10.1007/s10597-009-9200-0
-
(2009)
Community Mental Health Journal
, vol.45
, pp. 251-254
-
-
Cates, M.E.1
Jackson, C.W.2
Feldman, J.M.3
Stimmel, A.E.4
Woolley, T.W.5
-
9
-
-
84860991804
-
Safety of low doses of quetiapine when used for insomnia
-
doi:10.1345/aph.1Q697
-
Coe, H.V., & Hong, I.S. (2012). Safety of low doses of quetiapine when used for insomnia. Annals of Pharmacotherapy, 46, 718-722. doi:10.1345/aph.1Q697
-
(2012)
Annals of Pharmacotherapy
, vol.46
, pp. 718-722
-
-
Coe, H.V.1
Hong, I.S.2
-
10
-
-
3843142813
-
Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects
-
Cohrs, S., Pohlmann, K., Guan, Z., Jordan, W., Meier, A., Huether, G., Rodenbeck, A. (2004). Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology, 174, 414-420.
-
(2004)
Psychopharmacology
, vol.174
, pp. 414-420
-
-
Cohrs, S.1
Pohlmann, K.2
Guan, Z.3
Jordan, W.4
Meier, A.5
Huether, G.6
Rodenbeck, A.7
-
11
-
-
1842774440
-
Sleep-promoting properties of quetiapine in healthy subjects
-
Cohrs, S., Rodenbeck, A., Guan, Z., Pohlmann, K., Jordan, W., Meier, A., & Rüther, E. (2004). Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology, 174, 421-429.
-
(2004)
Psychopharmacology
, vol.174
, pp. 421-429
-
-
Cohrs, S.1
Rodenbeck, A.2
Guan, Z.3
Pohlmann, K.4
Jordan, W.5
Meier, A.6
Rüther, E.7
-
12
-
-
80054810300
-
National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders
-
doi:10.1176/appi.ajp.2011.11010087
-
Comer, J.S., Mojtabai, R.O., & Olfson, M. (2011). National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. American Journal of Psychiatry, 168, 1057-1065. doi:10.1176/appi.ajp.2011.11010087
-
(2011)
American Journal of Psychiatry
, vol.168
, pp. 1057-1065
-
-
Comer, J.S.1
Mojtabai, R.O.2
Olfson, M.3
-
13
-
-
34248232941
-
Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions
-
Compton, W.M., Thomas, Y.F., Stinson, F.S., & Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64, 566-576.
-
(2007)
Archives of General Psychiatry
, vol.64
, pp. 566-576
-
-
Compton, W.M.1
Thomas, Y.F.2
Stinson, F.S.3
Grant, B.F.4
-
14
-
-
42549085631
-
Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder
-
doi:10.1089/cap.2006.0007
-
Conner, D.F., McLaughlin, T.J., & Jeffers-Terry, M. (2008). Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. Journal of Child and Adolescent Psychopharmacology, 18, 140-156. doi:10.1089/cap.2006.0007
-
(2008)
Journal of Child and Adolescent Psychopharmacology
, vol.18
, pp. 140-156
-
-
Conner, D.F.1
McLaughlin, T.J.2
Jeffers-Terry, M.3
-
15
-
-
84856325555
-
Tolerability of extended-release quetiapine fumarate compared with immediaterelease quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: A randomised, double-blind, parallel-group study
-
doi:10.1002/gps.2720
-
De Deyn, P.P., Eriksson, H., & Svensson, H. (2012). Tolerability of extended-release quetiapine fumarate compared with immediaterelease quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: A randomised, double-blind, parallel-group study. International Journal of Geriatric Psychiatry, 27, 296-304. doi:10.1002/gps.2720
-
(2012)
International Journal of Geriatric Psychiatry
, vol.27
, pp. 296-304
-
-
de Deyn, P.P.1
Eriksson, H.2
Svensson, H.3
-
16
-
-
74949114615
-
Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study
-
Devlin, J.W., Roberts, R.J., Fong, J.J., Skrobik, Y., Riker, R.R., Hill, N.S., Garpestad, E. (2010). Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study. Critical Care Medicine, 38, 419-427.
-
(2010)
Critical Care Medicine
, vol.38
, pp. 419-427
-
-
Devlin, J.W.1
Roberts, R.J.2
Fong, J.J.3
Skrobik, Y.4
Riker, R.R.5
Hill, N.S.6
Garpestad, E.7
-
17
-
-
79551572553
-
Quetiapine for sleep in patients with dementia
-
doi:10.4140/TCP.n.2010.676
-
Dolder, C.R., & McKinsey, J. (2010). Quetiapine for sleep in patients with dementia. The Consultant Pharmacist, 25, 676-679. doi:10.4140/TCP.n.2010.676
-
(2010)
The Consultant Pharmacist
, vol.25
, pp. 676-679
-
-
Dolder, C.R.1
McKinsey, J.2
-
18
-
-
0035210918
-
The impact of delirium in the intensive care unit on hospital length of stay
-
Ely, E.W., Gautam, S., Margolin, R., Francis, J., May, L., Speroff, T., Inouye, S.K. (2001). The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Medicine, 27, 1892-1900.
-
(2001)
Intensive Care Medicine
, vol.27
, pp. 1892-1900
-
-
Ely, E.W.1
Gautam, S.2
Margolin, R.3
Francis, J.4
May, L.5
Speroff, T.6
Inouye, S.K.7
-
19
-
-
77954437393
-
Quetiapine in substance use disorders, abuse and dependence possibility: A review
-
Erdogan, S. (2010). Quetiapine in substance use disorders, abuse and dependence possibility: A review. Turkish Journal of Psychiatry, 21, 167-175.
-
(2010)
Turkish Journal of Psychiatry
, vol.21
, pp. 167-175
-
-
Erdogan, S.1
-
20
-
-
79955616401
-
The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study
-
Gabriel, A. (2011). The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study. La Clinica Terapeutica, 162, 113-118.
-
(2011)
La Clinica Terapeutica
, vol.162
, pp. 113-118
-
-
Gabriel, A.1
-
21
-
-
0038170049
-
Quetiapine in the treatment of borderline personality disorder
-
Hilger, E., Barnas, C., & Kasper, S. (2003). Quetiapine in the treatment of borderline personality disorder. World Journal of Biological Psychiatry, 4, 42-44.
-
(2003)
World Journal of Biological Psychiatry
, vol.4
, pp. 42-44
-
-
Hilger, E.1
Barnas, C.2
Kasper, S.3
-
22
-
-
0002635865
-
Anxiety disorders
-
In R.E. Hales, S.C. Yudofsky, & G.O. Gabbard (Eds.), 5th ed.). Arlington, VA: American Psychiatric Publishing
-
Hollander, E., & Simeon, D. (2010). Anxiety disorders. In R.E. Hales, S.C. Yudofsky, & G.O. Gabbard (Eds.), The American Psychiatric Publishing textbook of clinical psychiatry (5th ed.). Arlington, VA: American Psychiatric Publishing.
-
(2010)
The American Psychiatric Publishing Textbook of Clinical Psychiatry
-
-
Hollander, E.1
Simeon, D.2
-
23
-
-
23644433193
-
Quetiapine for insomnia in Parkinson disease: Results from an openlabel trial
-
Juri, C., Chaná, P., Tapia, J., Kunstmann, C., & Parrao, T. (2005). Quetiapine for insomnia in Parkinson disease: Results from an openlabel trial. Clinical Neuropharmacology, 28, 185-187.
-
(2005)
Clinical Neuropharmacology
, vol.28
, pp. 185-187
-
-
Juri, C.1
Chaná, P.2
Tapia, J.3
Kunstmann, C.4
Parrao, T.5
-
24
-
-
34447520132
-
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of type A and type B alcoholism
-
Kampman, K.M., Pettinati, H.M., Lynch, K.G., Whittingham, T., Macfadden, W., Dackis, C., O'Brien, C.P. (2007). A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of type A and type B alcoholism. Journal of Clinical Psychopharmacology, 26, 344-351.
-
(2007)
Journal of Clinical Psychopharmacology
, vol.26
, pp. 344-351
-
-
Kampman, K.M.1
Pettinati, H.M.2
Lynch, K.G.3
Whittingham, T.4
Macfadden, W.5
Dackis, C.6
O'Brien, C.P.7
-
25
-
-
78650809435
-
Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebocontrolled trial
-
doi:10.1097/ YIC.0b013e32833e34d9
-
Katzman, M.A., Brawman-Mintzer, O., Reyes, E.B., Olausson, B., Liu, S., & Eriksson, H. (2011). Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebocontrolled trial. International Clinical Psychopharmacology, 26, 11-24. doi:10.1097/ YIC.0b013e32833e34d9
-
(2011)
International Clinical Psychopharmacology
, vol.26
, pp. 11-24
-
-
Katzman, M.A.1
Brawman-Mintzer, O.2
Reyes, E.B.3
Olausson, B.4
Liu, S.5
Eriksson, H.6
-
26
-
-
53149142767
-
Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, openlabel pilot trial
-
doi:10.1016/j.janxdis.2008.03.002
-
Katzman, M.A., Vermani, M., Jacobs, L., Marcus, M., Kong, B., Lessard, S., Gendron, A. (2008). Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, openlabel pilot trial. Journal of Anxiety Disorders, 22, 1480-1486. doi:10.1016/j.janxdis.2008.03.002
-
(2008)
Journal of Anxiety Disorders
, vol.22
, pp. 1480-1486
-
-
Katzman, M.A.1
Vermani, M.2
Jacobs, L.3
Marcus, M.4
Kong, B.5
Lessard, S.6
Gendron, A.7
-
27
-
-
40949128787
-
Quetiapine for the treatment of cocaine dependence: An open-label trial
-
doi:10.1097/JCP.0b013e318166f50d
-
Kennedy, A., Wood, A.E., Saxon, A.J., Malte, C., Harvey, M., Jurik, J., Tapp, A. (2008). Quetiapine for the treatment of cocaine dependence: An open-label trial. Journal of Clinical Psychopharmacology, 28, 221-224. doi:10.1097/JCP.0b013e318166f50d
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, pp. 221-224
-
-
Kennedy, A.1
Wood, A.E.2
Saxon, A.J.3
Malte, C.4
Harvey, M.5
Jurik, J.6
Tapp, A.7
-
28
-
-
79960573121
-
A randomized, double-blind study of oncedaily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
-
doi:10.1097/JCP.0b013e318224864d
-
Khan, A., Joyce, M., Atkinson, S., Eggens, I., Baldytcheva, I., & Eriksson, H. (2011). A randomized, double-blind study of oncedaily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder. Journal of Clinical Psychopharmacology, 31, 418-428. doi:10.1097/JCP.0b013e318224864d
-
(2011)
Journal of Clinical Psychopharmacology
, vol.31
, pp. 418-428
-
-
Khan, A.1
Joyce, M.2
Atkinson, S.3
Eggens, I.4
Baldytcheva, I.5
Eriksson, H.6
-
29
-
-
34248574732
-
Efficacy and tolerability of quetiapine in cluster B personality disorders: An open-label study
-
doi:10.1080/13651500600885556
-
Le Bloc'h, Y., Baumann, P., Stigler, M., Eap, C.B., & Zullino, D.F. (2007). Efficacy and tolerability of quetiapine in cluster B personality disorders: An open-label study. International Journal of Psychiatry in Clinical Practice, 11, 123-128. doi:10.1080/13651500600885556
-
(2007)
International Journal of Psychiatry In Clinical Practice
, vol.11
, pp. 123-128
-
-
Le Bloc'h, Y.1
Baumann, P.2
Stigler, M.3
Eap, C.B.4
Zullino, D.F.5
-
30
-
-
84857503966
-
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcoholdependent patients
-
doi:10.1111/j.1530-0277.2011.01649.x
-
Litten, R.Z., Fertig, J.B., Falk, D.E., Ryan, M.L., Mattson, M.E., Collins, J.F., Stout, R. (2012). A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcoholdependent patients. Alcoholism Clinical and Experimental Research, 36, 406-416. doi:10.1111/j.1530-0277.2011.01649.x
-
(2012)
Alcoholism Clinical and Experimental Research
, vol.36
, pp. 406-416
-
-
Litten, R.Z.1
Fertig, J.B.2
Falk, D.E.3
Ryan, M.L.4
Mattson, M.E.5
Collins, J.F.6
Stout, R.7
-
31
-
-
77956155318
-
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder
-
doi:10.1592/phco.30.9.942
-
Lorenz, R.A., Jackson, C.W., & Saitz, M. (2010). Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. Pharmacotherapy, 30, 942-951. doi:10.1592/phco.30.9.942
-
(2010)
Pharmacotherapy
, vol.30
, pp. 942-951
-
-
Lorenz, R.A.1
Jackson, C.W.2
Saitz, M.3
-
32
-
-
84863527915
-
Postoperative delirium: A 76-year-old woman with delirium following surgery
-
Marcantonio, E.R. (2012). Postoperative delirium: A 76-year-old woman with delirium following surgery. Journal of the American Medical Association, 308, 73-81.
-
(2012)
Journal of the American Medical Association
, vol.308
, pp. 73-81
-
-
Marcantonio, E.R.1
-
33
-
-
48249140622
-
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics
-
doi:10.1002/hup.944
-
Martinotti, G., Andreoli, S., Di Nicola, M., Di Giannantonio, M., Sarchiapone, M., & Janiri, L. (2008). Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Human Psychopharmacology, 23, 417-424. doi:10.1002/hup.944
-
(2008)
Human Psychopharmacology
, vol.23
, pp. 417-424
-
-
Martinotti, G.1
Andreoli, S.2
Di Nicola, M.3
Di Giannantonio, M.4
Sarchiapone, M.5
Janiri, L.6
-
34
-
-
36049015484
-
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study
-
McIntyre, A., Gendron, A., & McIntyre, A. (2007). Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study. Depression & Anxiety, 24, 487-494.
-
(2007)
Depression & Anxiety
, vol.24
, pp. 487-494
-
-
McIntyre, A.1
Gendron, A.2
McIntyre, A.3
-
35
-
-
83055184288
-
Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: A randomized, placebo controlled and active-controlled study
-
doi:10.1097/ YIC.0b013e32834d9f49
-
Merideth, C., Cutler, A.J., She, F., & Eriksson, H. (2012). Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: A randomized, placebo controlled and active-controlled study. International Clinical Psychopharmacology, 27, 40-54. doi:10.1097/ YIC.0b013e32834d9f49
-
(2012)
International Clinical Psychopharmacology
, vol.27
, pp. 40-54
-
-
Merideth, C.1
Cutler, A.J.2
She, F.3
Eriksson, H.4
-
36
-
-
33847197130
-
Clinical experience of quetiapine in 24 elderly patients with delirium
-
doi:10.1046/ j.1479-8301.2003.00012.x
-
Omura, K., & Amano, N. (2003). Clinical experience of quetiapine in 24 elderly patients with delirium. Psychogeriatrics, 3, 69-72. doi:10.1046/ j.1479-8301.2003.00012.x
-
(2003)
Psychogeriatrics
, vol.3
, pp. 69-72
-
-
Omura, K.1
Amano, N.2
-
37
-
-
27544452471
-
Reduction of opioid-withdrawal symptoms with quetiapine
-
Pinkofsky, H.B., Hahn, A.M., Campbell, F.A., Rueda, J., Daley, D.C., & Douaihy, A.B. (2005). Reduction of opioid-withdrawal symptoms with quetiapine. Journal of Clinical Psychiatry, 66, 1285-1288.
-
(2005)
Journal of Clinical Psychiatry
, vol.66
, pp. 1285-1288
-
-
Pinkofsky, H.B.1
Hahn, A.M.2
Campbell, F.A.3
Rueda, J.4
Daley, D.C.5
Douaihy, A.B.6
-
39
-
-
34548565620
-
Quetiapine versus risperidone in elderly patients with behavioral and psychological symptoms of dementia: Efficacy, safety, and cognitive function
-
Rainer, M., Haushofer, M., Pfolz, H., Struhal, C., & Wick, W. (2007). Quetiapine versus risperidone in elderly patients with behavioral and psychological symptoms of dementia: Efficacy, safety, and cognitive function. European Psychiatry, 22, 395-403.
-
(2007)
European Psychiatry
, vol.22
, pp. 395-403
-
-
Rainer, M.1
Haushofer, M.2
Pfolz, H.3
Struhal, C.4
Wick, W.5
-
40
-
-
82955198411
-
A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving
-
doi:10.1007/s00213-011-2287-3
-
Ray, L.A., Chin, P.F., Heydari, A., & Miotto, K. (2011). A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology, 217, 341-351. doi:10.1007/s00213-011-2287-3
-
(2011)
Psychopharmacology
, vol.217
, pp. 341-351
-
-
Ray, L.A.1
Chin, P.F.2
Heydari, A.3
Miotto, K.4
-
41
-
-
34548418494
-
Additional evidence of the abuse potential of quetiapine
-
Reeves, R.R., & Brister, J.C. (2007). Additional evidence of the abuse potential of quetiapine. Southern Medical Journal, 100, 834-836.
-
(2007)
Southern Medical Journal
, vol.100
, pp. 834-836
-
-
Reeves, R.R.1
Brister, J.C.2
-
42
-
-
84927016502
-
Pharmacotherapy in severe personality disorders: A critical review
-
In B. van Luyn & S. Akthar (Eds.), New York: Cambridge University
-
Rinne, T., & Ingenhoven, T. (2007). Pharmacotherapy in severe personality disorders: A critical review. In B. van Luyn & S. Akthar (Eds.), Severe personality disorders (pp. 137-163). New York: Cambridge University.
-
(2007)
Severe Personality Disorders
, pp. 137-163
-
-
Rinne, T.1
Ingenhoven, T.2
-
43
-
-
54749118885
-
Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: An open label trial
-
doi:10.1055/s-2008-1076730
-
Roepke, S., Merkl, A., Dams, A., Ziegenhorn, A., Anghelescu, I.G., Heuser, I., & Lammers, C.H. (2008). Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: An open label trial. Pharmacopsychiatry, 41, 176-181. doi:10.1055/s-2008-1076730
-
(2008)
Pharmacopsychiatry
, vol.41
, pp. 176-181
-
-
Roepke, S.1
Merkl, A.2
Dams, A.3
Ziegenhorn, A.4
Anghelescu, I.G.5
Heuser, I.6
Lammers, C.H.7
-
44
-
-
57149139518
-
Quetiapine in patients with borderline personality disorder: An openlabel trial
-
doi:10.1080/10401230802467545
-
Romine, A., Brown, E., Thuras, P., Lee, S., & Schulz, S.S. (2008). Quetiapine in patients with borderline personality disorder: An openlabel trial. Annals of Clinical Psychiatry, 20, 219-226. doi:10.1080/10401230802467545
-
(2008)
Annals of Clinical Psychiatry
, vol.20
, pp. 219-226
-
-
Romine, A.1
Brown, E.2
Thuras, P.3
Lee, S.4
Schulz, S.S.5
-
45
-
-
11344260664
-
Potential benefits of quetiapine in the treatment of substance abuse disorders
-
Sattar, P.S., Bhatia, S.C., & Petty, F. (2004). Potential benefits of quetiapine in the treatment of substance abuse disorders. Journal of Psychiatric Neurosciences, 29, 452-457.
-
(2004)
Journal of Psychiatric Neurosciences
, vol.29
, pp. 452-457
-
-
Sattar, P.S.1
Bhatia, S.C.2
Petty, F.3
-
46
-
-
33644922637
-
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
-
Schneider, L.S., Dagerman, K., & Insel, P.S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210.
-
(2006)
American Journal of Geriatric Psychiatry
, vol.14
, pp. 191-210
-
-
Schneider, L.S.1
Dagerman, K.2
Insel, P.S.3
-
47
-
-
34249982606
-
Successful treatment with quetiapine for delirium in terminally ill cancer patients
-
doi:10.1111/j.14798301.2007.00182.x
-
Shinno, H., Matsuoka, T., Yamamoto, O., Noma, Y., Hikasa, S., Takebayashi, M., & Horiguchi, J. (2007). Successful treatment with quetiapine for delirium in terminally ill cancer patients. Psychogeriatrics, 7, 64-68. doi:10.1111/j.14798301.2007.00182.x
-
(2007)
Psychogeriatrics
, vol.7
, pp. 64-68
-
-
Shinno, H.1
Matsuoka, T.2
Yamamoto, O.3
Noma, Y.4
Hikasa, S.5
Takebayashi, M.6
Horiguchi, J.7
-
48
-
-
41849148995
-
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: Preliminary findings
-
doi:10.1007/s00213-008-1087-x
-
Simon, N.M., Connor, K.M., Lebeau, R.T., Hoge, E.A., Worthington, J.J., 3rd, Zhang W., Pollack, M.H. (2008). Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: Preliminary findings. Psychopharmacology, 197, 675-681. doi:10.1007/s00213-008-1087-x
-
(2008)
Psychopharmacology
, vol.197
, pp. 675-681
-
-
Simon, N.M.1
Connor, K.M.2
Lebeau, R.T.3
Hoge, E.A.4
Worthington III, J.J.5
Zhang, W.6
Pollack, M.H.7
-
50
-
-
83855161521
-
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: An analysis of pooled data from three 8-week placebo-controlled studies
-
doi:10.1002/hup.1256
-
Stein, D.J., Bandelow, B., Merideth, C., Olausson, B., Szamosi, J., & Eriksson, H. (2011). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: An analysis of pooled data from three 8-week placebo-controlled studies. Human Psychopharmacology, 26, 614-628. doi:10.1002/hup.1256
-
(2011)
Human Psychopharmacology
, vol.26
, pp. 614-628
-
-
Stein, D.J.1
Bandelow, B.2
Merideth, C.3
Olausson, B.4
Szamosi, J.5
Eriksson, H.6
-
51
-
-
84882698643
-
-
Study for off-label drug use urgently needed
-
Study for off-label drug use urgently needed. (2008). PharmacoEconomics & Outcomes News, 568, 8.
-
(2008)
PharmacoEconomics & Outcomes News
, vol.568
, pp. 8
-
-
-
52
-
-
46749095495
-
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
-
doi:10.1176/ appi.ajp.2008.07111779
-
Sultzer, D.L., Davis, S.M., Tariot, P.N., Dagerman, K.S., Lebowitz, B.D., Lyketsos, C.G., Schneider, L.S. (2008). Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial. American Journal of Psychiatry, 165, 844-854. doi:10.1176/ appi.ajp.2008.07111779
-
(2008)
American Journal of Psychiatry
, vol.165
, pp. 844-854
-
-
Sultzer, D.L.1
Davis, S.M.2
Tariot, P.N.3
Dagerman, K.S.4
Lebowitz, B.D.5
Lyketsos, C.G.6
Schneider, L.S.7
-
53
-
-
77957906545
-
A randomized controlled trial of quetiapine versus placebo in the treatment of delirium
-
doi:10.1016/j.jpsychores.2010.05.006
-
Tahir, T.A., Eeles, E., Karapareddy, V., Muthuvelu, P., Chapple, S., Phillips, B., Bisson, J.I. (2010). A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. Journal of Psychosomatic Research, 69, 485-490. doi:10.1016/j.jpsychores.2010.05.006
-
(2010)
Journal of Psychosomatic Research
, vol.69
, pp. 485-490
-
-
Tahir, T.A.1
Eeles, E.2
Karapareddy, V.3
Muthuvelu, P.4
Chapple, S.5
Phillips, B.6
Bisson, J.I.7
-
54
-
-
84882733408
-
Quetiapine for the treatment of cocaine dependence
-
Tapp, A., Wood, A.E., Kennedy, A., & Sylvers, P. (2011). Quetiapine for the treatment of cocaine dependence. European Psychiatry, 26, 113.
-
(2011)
European Psychiatry
, vol.26
, pp. 113
-
-
Tapp, A.1
Wood, A.E.2
Kennedy, A.3
Sylvers, P.4
-
55
-
-
33748585223
-
Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled trial
-
Tariot, P.N., Schneider, L., Katz, I.R., Mintzer, J.E., Street, J., Copenhaver, M., & Williams-Hughes, C. (2006). Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled trial. American Journal of Geriatric Psychiatry, 14, 767-776.
-
(2006)
American Journal of Geriatric Psychiatry
, vol.14
, pp. 767-776
-
-
Tariot, P.N.1
Schneider, L.2
Katz, I.R.3
Mintzer, J.E.4
Street, J.5
Copenhaver, M.6
Williams-Hughes, C.7
-
56
-
-
77954527766
-
Quetiapine for primary insomnia: A double blind, randomized controlled trial
-
Tassniyom, K., Paholpak, S., Tassniyom, S., & Kiewyoo, J. (2010). Quetiapine for primary insomnia: A double blind, randomized controlled trial. Journal of Medical Association of Thailand, 93, 729-734.
-
(2010)
Journal of Medical Association of Thailand
, vol.93
, pp. 729-734
-
-
Tassniyom, K.1
Paholpak, S.2
Tassniyom, S.3
Kiewyoo, J.4
-
57
-
-
84859964525
-
Atypical antipsychotic medications to control symptoms of delirium in children and adolescents
-
Turkel, S.B., Jacobson, J., Munzig, E., & Tavaré, C.J. (2012). Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 22, 126-130. doi:10.1089/cap.2011.0084
-
(2012)
Journal of Child and Adolescent Psychopharmacology
, vol.22
, pp. 126-130
-
-
Turkel, S.B.1
Jacobson, J.2
Munzig, E.3
Tavaré, C.J.4
-
58
-
-
84882717534
-
-
U.S. Department of Justice. (2010, April 27), [Press release]. Retrieved from
-
U.S. Department of Justice. (2010, April 27). million for off label drug marketing [Press release]. Retrieved from http://www.justice.gov/opa/pr/2010/April/10-civ-487.html
-
Million For Off Label Drug Marketing
-
-
-
59
-
-
73449086967
-
Quetiapine treatment and improved cognitive functioning in borderline personality disorder
-
doi:10.1002/hup.1075
-
Van den Eynde, F., De Saedeleer, S., Naudts, K., Day, J., Vogels, C., van Heeringen, C., & Audenaert, K. (2009). Quetiapine treatment and improved cognitive functioning in borderline personality disorder. Human Psychopharmacology, 24, 646-649. doi:10.1002/hup.1075
-
(2009)
Human Psychopharmacology
, vol.24
, pp. 646-649
-
-
Van den Eynde, F.1
de Saedeleer, S.2
Naudts, K.3
Day, J.4
Vogels, C.5
van Heeringen, C.6
Audenaert, K.7
-
60
-
-
40949127907
-
Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder
-
doi:10.1097/ JCP.0b013e318166c4bf
-
Van den Eynde, F., Senturk, V., Naudts, K., Vogels, C., Bernagie, K., Thas, O., Audenaert, K. (2008). Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. Journal of Clinical Psychopharmacology, 28, 147-155. doi:10.1097/ JCP.0b013e318166c4bf
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, pp. 147-155
-
-
Van den Eynde, F.1
Senturk, V.2
Naudts, K.3
Vogels, C.4
Bernagie, K.5
Thas, O.6
Audenaert, K.7
-
61
-
-
27544468326
-
Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: Impulsivity as main target
-
Villeneuve, E., & Lemelin, S. (2005). Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: Impulsivity as main target. Journal of Clinical Psychiatry, 66, 1298-1303.
-
(2005)
Journal of Clinical Psychiatry
, vol.66
, pp. 1298-1303
-
-
Villeneuve, E.1
Lemelin, S.2
-
62
-
-
0141844438
-
Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine
-
Walker, C., Thomas, J., & Allen, T.S. (2008). Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine. International Journal of Offender Therapy and Comparative Criminology, 47, 556-567.
-
(2008)
International Journal of Offender Therapy and Comparative Criminology
, vol.47
, pp. 556-567
-
-
Walker, C.1
Thomas, J.2
Allen, T.S.3
-
63
-
-
79959620914
-
Quetiapine in refractory hyperactive and mixed intensive care delirium: A case series
-
Wan, R.Y., Kasliwal, M., McKenzie, C.A., & Barrett, N.A. (2011). Quetiapine in refractory hyperactive and mixed intensive care delirium: A case series. Critical Care, 15, R159.
-
(2011)
Critical Care
, vol.15
-
-
Wan, R.Y.1
Kasliwal, M.2
McKenzie, C.A.3
Barrett, N.A.4
-
64
-
-
38349187275
-
Quetiapine in primary insomnia: A pilot study
-
Wiegand, M.H., Landry, F., Brückner, T., Pohl, C., Vesely, Z., & Jahn, T. (2008). Quetiapine in primary insomnia: A pilot study. Psychopharmacology, 196, 337-338.
-
(2008)
Psychopharmacology
, vol.196
, pp. 337-338
-
-
Wiegand, M.H.1
Landry, F.2
Brückner, T.3
Pohl, C.4
Vesely, Z.5
Jahn, T.6
-
65
-
-
77957681242
-
Statistically significant increase in weight gain caused by low-dose quetiapine
-
doi:10.1592/phco.30.10.1011
-
Williams, S.G., Alinejad, N.A., Williams, J.A., & Cruess, D.F. (2010). Statistically significant increase in weight gain caused by low-dose quetiapine. Pharmacotherapy, 30, 1011-1015. doi:10.1592/phco.30.10.1011
-
(2010)
Pharmacotherapy
, vol.30
, pp. 1011-1015
-
-
Williams, S.G.1
Alinejad, N.A.2
Williams, J.A.3
Cruess, D.F.4
-
66
-
-
33847132248
-
Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study
-
Zhong, K.X., Tariot, P.N., Mintzer, J., Minkwitz, M.C., & Devine, N.A. (2007). Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study. Current Alzheimer Research, 4, 81-93.
-
(2007)
Current Alzheimer Research
, vol.4
, pp. 81-93
-
-
Zhong, K.X.1
Tariot, P.N.2
Mintzer, J.3
Minkwitz, M.C.4
Devine, N.A.5
|